Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Where Do AQP4 Antibodies Fit in the Pathogenesis of NMO?
Cost-effectiveness of early initiation of fingolimod versus delayed initiation after 1 year of intramuscular interferon Beta-1a in patients with multiple sclerosis.
Complement receptor-3 negatively regulates the phagocytosis of degenerated myelin through tyrosine kinase Syk and cofilin.
Low-contrast multifocal visual evoked potentials: Identifying more shades of gray in MS.
Anesthetic management of a parturient with neuromyelitis optica.
Role of Venoplasty for Treatment of Multiple Sclerosis: Value of Open-label Studies and Surrogate Treatment Outcomes.
Assessing the long-term clinical benefit of prolonged-release fampridine tablets in a real-world setting: a review of 67 cases.
Natalizumab in spinal multiple sclerosis in a daily clinical setting.
Role of adenosine in oligodendrocyte precursor maturation.
Natalizumab in relapsing-remitting multiple sclerosis.
UCSF Neuroimmunology Seminar
Longitudinal extensive transverse myelitis and optic neuritis: the elements for the diagnosis of neuromyelitis optica.
Determinants of the severity of comorbid migraine in multiple sclerosis.
Cyclical suicidal ideation following natalizumab infusion for multiple sclerosis.
Biogen Idec and Elan submit applications for first-line use of Tysabri in anti-JCV antibody negative patients with MS
Nitrous oxide induced myeloneuropathy: a case report.
Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice.
Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?
Merck KGaA to try again to get approval for MS pill cladribine
Regulated microRNAs in the CSF of patients with multiple sclerosis: A case-control study.
A comparative study of CSF neurofilament light and heavy chain protein in MS.
[Progress of demyelinating animal models in the central nervous system].
Investigation of the relationship between vitamin D and bone mineral density in newly diagnosed multiple sclerosis.
ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.

Pages